Table 2. Associations between FGF21 and Cardiovascular Diseases.
CV end-point | Result | Reference |
---|---|---|
CV mortality | Elevated serum FGF21 predicted combined morbidity and mortality in T2DM | [27] |
Total CV outcomes | Elevated plasma FGF21 | [21] |
CHD | Elevated serum FGF21 | [22] |
Carotid artery IMT | Elevated serum FGF21 | [23,24] |
Arterial stiffness | Brachial-ankle pulse wave velocity independently associated with serum FGF21 | [26] |
LEAD | Elevated serum FGF21 | [25] |
FGF21, fibroblast growth factor 21; CV, cardiovascular; T2DM, type 2 diabetes mellitus; CHD, coronary heart disease; IMT, intima-media thickness; LEAD, lower extremity atherosclerotic disease.